Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
$810M |
| 2 |
Intuitive Surgical
ISRG
|
$705M |
| 3 |
S&P Global
SPGI
|
$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
$605M |
| 2 |
FedEx
FDX
|
$587M |
| 3 |
Monster Beverage
MNST
|
$395M |
| 4 |
McDonald's
MCD
|
$387M |
| 5 |
Booking.com
BKNG
|
$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Standard BioTools
LAB
$531M
| – | – |
-68,791
| Closed | -$410K |
|
677
Littelfuse
LFUS
$6.52B
| – | – |
-31,376
| Closed | -$7.16M |
|
678
Match Group
MTCH
$9.27B
| – | – |
-15,740
| Closed | -$610K |
|
|
NAK
679
Northern Dynasty Minerals
NAK
$454M
| – | – |
-1,763,422
| Closed | -$955K |
|
680
Nutanix
NTNX
$20.3B
| – | – |
-11,872
| Closed | -$612K |
|
681
Nu Skin
NUS
$570M
| – | – |
-21,862
| Closed | -$1.71M |
|
682
OceanFirst Financial
OCFC
$1.05B
| – | – |
-37,293
| Closed | -$1.12M |
|
683
ON Semiconductor
ON
$19.8B
| – | – |
-29,611
| Closed | -$658K |
|
684
Oracle
ORCL
$673B
| – | – |
-458,347
| Closed | -$20.2M |
|
685
Ovid Therapeutics
OVID
$87.5M
| – | – |
-394,436
| Closed | -$3.08M |
|
686
Provident Financial Services
PFS
$2.6B
| – | – |
-60,246
| Closed | -$1.66M |
|
687
Pinnacle West Capital
PNW
$10.5B
| – | – |
-580,669
| Closed | -$46.8M |
|
688
Power Integrations
POWI
$2.54B
| – | – |
-9,466
| Closed | -$346K |
|
689
Royal Caribbean
RCL
$95.6B
| – | – |
-296,585
| Closed | -$30.7M |
|
690
REV Group
REVG
$3.03B
| – | – |
-509,537
| Closed | -$8.67M |
|
691
RLI Corp
RLI
$6.25B
| – | – |
-8,732
| Closed | -$289K |
|
692
Sally Beauty Holdings
SBH
$1.44B
| – | – |
-41,979
| Closed | -$673K |
|
693
Starbucks
SBUX
$95.4B
| – | – |
-107,612
| Closed | -$5.26M |
|
694
Sealed Air
SEE
$4.82B
| – | – |
-2,401,902
| Closed | -$102M |
|
695
Silicon Laboratories
SLAB
$4.43B
| – | – |
-15,529
| Closed | -$1.55M |
|
696
Semtech
SMTC
$5.24B
| – | – |
-13,812
| Closed | -$650K |
|
697
Schneider National
SNDR
$4.3B
| – | – |
-593,261
| Closed | -$16.3M |
|
698
Supernus Pharmaceuticals
SUPN
$2.59B
| – | – |
-9,837
| Closed | -$589K |
|
699
Savara
SVRA
$671M
| – | – |
-794,234
| Closed | -$8.99M |
|
700
TransDigm Group
TDG
$72.1B
| – | – |
-1,832
| Closed | -$632K |
|